SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-005142
Filing Date
2023-01-25
Accepted
2023-01-25 16:35:29
Documents
13
Period of Report
2023-01-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea172211-8k_biotechacq.htm   iXBRL 8-K 33933
  Complete submission text file 0001213900-23-005142.txt   266374

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE biotu-20230119.xsd EX-101.SCH 4332
3 XBRL DEFINITION FILE biotu-20230119_def.xml EX-101.DEF 27671
4 XBRL LABEL FILE biotu-20230119_lab.xml EX-101.LAB 38403
5 XBRL PRESENTATION FILE biotu-20230119_pre.xml EX-101.PRE 26288
7 EXTRACTED XBRL INSTANCE DOCUMENT ea172211-8k_biotechacq_htm.xml XML 7157
Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Filer) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39935 | Film No.: 23552865
SIC: 6770 Blank Checks